HU219587B - Eljárás cefém-prodrog-észterek előállítására - Google Patents
Eljárás cefém-prodrog-észterek előállítására Download PDFInfo
- Publication number
- HU219587B HU219587B HU9300374A HU9300374A HU219587B HU 219587 B HU219587 B HU 219587B HU 9300374 A HU9300374 A HU 9300374A HU 9300374 A HU9300374 A HU 9300374A HU 219587 B HU219587 B HU 219587B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- compound
- acid
- ethyl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4204349 | 1992-02-14 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9300374D0 HU9300374D0 (en) | 1993-04-28 |
| HUT64350A HUT64350A (en) | 1993-12-28 |
| HU219587B true HU219587B (hu) | 2001-05-28 |
Family
ID=6451660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9300374A HU219587B (hu) | 1992-02-14 | 1993-02-12 | Eljárás cefém-prodrog-észterek előállítására |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5589594A (sh) |
| EP (1) | EP0555769B1 (sh) |
| JP (1) | JP3426629B2 (sh) |
| KR (1) | KR100265191B1 (sh) |
| AT (1) | ATE184609T1 (sh) |
| CA (1) | CA2089441C (sh) |
| DE (1) | DE59309776D1 (sh) |
| DK (1) | DK0555769T3 (sh) |
| ES (1) | ES2137201T3 (sh) |
| FI (1) | FI109027B (sh) |
| GR (1) | GR3032076T3 (sh) |
| HU (1) | HU219587B (sh) |
| TW (1) | TW212181B (sh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2175167T3 (es) * | 1995-12-27 | 2002-11-16 | Hanmi Pharmaceutical Co Ltd | Procedimiento para la preparacion de cefdinir. |
| US5883247A (en) * | 1996-06-10 | 1999-03-16 | Hoffmann-La Roche Inc. | Preparation of cephem and isooxacephem derivatives |
| ITMI20012363A1 (it) * | 2001-11-09 | 2003-05-09 | Antibioticos Spa | Metodo per la sintesi di catene laterali di cefalosporine |
| GB0416380D0 (en) * | 2004-07-22 | 2004-08-25 | Sandoz Ag | Organic compounds |
| CN100448856C (zh) * | 2006-06-26 | 2009-01-07 | 山东金城医药化工股份有限公司 | 一种催化合成ae-活性酯的工艺 |
| ITMI20071628A1 (it) | 2007-08-06 | 2007-11-05 | Acs Dobfar Spa | Sintesi di 3-alchenilcefalosporine e nuovi intermedi utili ad esse correlati |
| WO2011029596A1 (en) | 2009-09-11 | 2011-03-17 | Lonza Ltd | Process for preparing 2-aminothiazol-4-yl-acetic acid derivates |
| WO2013018095A1 (en) * | 2011-08-01 | 2013-02-07 | Yissum Research And Development Of The Hebrew University Of Jerusalem Ltd. | Compounds and compositions for use in augmentation of glucose uptake and insulin secretion |
| CN102659713B (zh) * | 2012-05-07 | 2014-03-05 | 山东金城柯瑞化学有限公司 | 头孢地尼侧链酸活性酯的制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4668783A (en) * | 1974-12-19 | 1987-05-26 | Takeda Chemical Industries, Ltd. | Thiazolylacetamido cephalosporin compounds |
| US4298606A (en) * | 1974-12-19 | 1981-11-03 | Takeda Chemical Industries, Ltd. | Thiazolylacetamido compounds |
| DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
| JPS5760345B2 (sh) * | 1974-12-19 | 1982-12-18 | Takeda Chemical Industries Ltd | |
| US4203899A (en) * | 1974-12-19 | 1980-05-20 | Takeda Chemical Industries, Ltd. | Thiazolylacetamido compounds |
| DE2760123C2 (de) * | 1976-01-23 | 1986-04-30 | Roussel-Uclaf, Paris | 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
| JPS6011713B2 (ja) * | 1976-09-08 | 1985-03-27 | 武田薬品工業株式会社 | セフアロスポリン誘導体およびその製造法 |
| US4120690A (en) * | 1976-11-22 | 1978-10-17 | Gulf Oil Corporation | 2-Acylaminothiazol-4-ylacetamides as post-emergent selective herbicides |
| DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
| US4409215A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical Co., Ltd. | 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof |
| FR2476087A1 (fr) * | 1980-02-18 | 1981-08-21 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
| JPS5759894A (en) * | 1980-09-30 | 1982-04-10 | Sankyo Co Ltd | Cephalosporin for oral administration |
| US4486425A (en) * | 1980-09-30 | 1984-12-04 | Sankyo Company Limited | 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates |
| JPS5896091A (ja) * | 1981-12-01 | 1983-06-07 | Sankyo Co Ltd | ３−アルコキシメチルセフアロスポリン類の製造法 |
| US4948898A (en) * | 1982-06-03 | 1990-08-14 | Hoffmann-La Roche Inc. | Process for the manufacture of 1-sulpho-2-oxoazetidine derivatives |
| JPS604189A (ja) * | 1983-06-20 | 1985-01-10 | Sankyo Co Ltd | β−ラクタム系化合物の製造法 |
| JPS604190A (ja) * | 1983-06-21 | 1985-01-10 | Sankyo Co Ltd | セフアロスポリン誘導体の製法 |
| EP0156771A3 (en) * | 1984-03-29 | 1986-03-19 | Biochemie Gesellschaft M.B.H. | Cephalosporins |
| US5359057A (en) * | 1986-02-07 | 1994-10-25 | Hoffmann-La Roche Inc. | Acylation of amines |
| DE3804841A1 (de) * | 1988-02-17 | 1989-08-31 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
| DE3809561A1 (de) * | 1988-03-22 | 1989-10-05 | Hoechst Ag | Ester der 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroxyiminoacetamido)-3-methoxymethyl-3-cephem-4-carbonsaeure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen |
| US4935508A (en) * | 1988-08-23 | 1990-06-19 | Bristol-Myers Company | Process for cephem prodrug esters |
| DE3901405A1 (de) * | 1989-01-19 | 1990-07-26 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
| DE3905119A1 (de) * | 1989-02-20 | 1990-08-23 | Bayer Ag | Substituierte acrylsaeureester |
| DE3919259A1 (de) * | 1989-06-13 | 1990-12-20 | Hoechst Ag | Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung |
| US5063224A (en) * | 1990-07-09 | 1991-11-05 | Eli Lilly And Company | R-cefuroxime axetil |
| WO1992007840A1 (en) * | 1990-11-02 | 1992-05-14 | Taisho Pharmaceutical Co., Ltd. | Thiazole thioester derivative |
| YU48484B (sh) * | 1991-05-24 | 1998-09-18 | Hoechst Aktiengesellschaft | Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline |
| DE59209994D1 (de) * | 1991-09-07 | 2004-04-29 | Aventis Pharma Gmbh | Diastereomer des 3-Cephem-4-carbonsäure-1-(-isopropoxycarbonyloxy)ethylesters und Verfahren zu dessen Herstellung |
-
1992
- 1992-07-14 TW TW081105527A patent/TW212181B/zh not_active IP Right Cessation
-
1993
- 1993-02-04 AT AT93101722T patent/ATE184609T1/de active
- 1993-02-04 ES ES93101722T patent/ES2137201T3/es not_active Expired - Lifetime
- 1993-02-04 DE DE59309776T patent/DE59309776D1/de not_active Expired - Lifetime
- 1993-02-04 EP EP93101722A patent/EP0555769B1/de not_active Expired - Lifetime
- 1993-02-04 DK DK93101722T patent/DK0555769T3/da active
- 1993-02-11 FI FI930604A patent/FI109027B/fi not_active IP Right Cessation
- 1993-02-12 JP JP02418093A patent/JP3426629B2/ja not_active Expired - Lifetime
- 1993-02-12 HU HU9300374A patent/HU219587B/hu unknown
- 1993-02-12 KR KR1019930001929A patent/KR100265191B1/ko not_active IP Right Cessation
- 1993-02-12 CA CA002089441A patent/CA2089441C/en not_active Expired - Lifetime
- 1993-12-30 US US08/176,501 patent/US5589594A/en not_active Expired - Lifetime
-
1995
- 1995-06-06 US US08/470,422 patent/US5637721A/en not_active Expired - Lifetime
-
1999
- 1999-12-08 GR GR990403167T patent/GR3032076T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0555769T3 (da) | 2000-03-20 |
| DE59309776D1 (de) | 1999-10-21 |
| US5637721A (en) | 1997-06-10 |
| EP0555769A2 (de) | 1993-08-18 |
| CA2089441A1 (en) | 1993-08-15 |
| JPH069650A (ja) | 1994-01-18 |
| US5589594A (en) | 1996-12-31 |
| JP3426629B2 (ja) | 2003-07-14 |
| FI109027B (fi) | 2002-05-15 |
| KR930017908A (ko) | 1993-09-20 |
| HUT64350A (en) | 1993-12-28 |
| FI930604A0 (fi) | 1993-02-11 |
| EP0555769A3 (en) | 1993-11-24 |
| KR100265191B1 (ko) | 2000-09-15 |
| HU9300374D0 (en) | 1993-04-28 |
| TW212181B (sh) | 1993-09-01 |
| ATE184609T1 (de) | 1999-10-15 |
| EP0555769B1 (de) | 1999-09-15 |
| GR3032076T3 (en) | 2000-03-31 |
| FI930604A (fi) | 1993-08-15 |
| ES2137201T3 (es) | 1999-12-16 |
| CA2089441C (en) | 2004-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7244842B2 (en) | Amorphous hydrate of a cephalosporin antibiotic | |
| EP1572699B1 (en) | Crystalline cefdinir salts | |
| USRE47787E1 (en) | Process for preparing ceftaroline fosamil | |
| HU219587B (hu) | Eljárás cefém-prodrog-észterek előállítására | |
| HU182686B (en) | Process for preparing 7-/2-/2-amino-thiazolyl/-2-/1-carboxy-1,1-dialkyl-alkoxiimino-acetamido/-cefem-sulphoxides | |
| JPS6157316B2 (sh) | ||
| JP4856795B2 (ja) | セファロスポリン抗生物質の製造における新規な塩 | |
| US6878827B2 (en) | Process for producing anhydride of aminothiazole derivative | |
| US4866055A (en) | Cephalosporin derivatives and their crystalline derivatives | |
| KR910000238B1 (ko) | 티아졸 유도체의 제조방법 | |
| JP4022070B2 (ja) | 新規チアゾール化合物およびその製造方法 | |
| US20050032771A1 (en) | Process for the preparation of cefixime via alkyl-or aryl-sulfonates | |
| PL175011B1 (pl) | Sposób wytwarzania antybiotyku mono lub dihydratu dichlorowodorku cefepimu | |
| JPS60222489A (ja) | ７−アミノセフエム化合物の製法 | |
| US5594130A (en) | Preparation of a cephalosporin antibiotic using the syn-isomer of a thiazolyl intermediate | |
| JP2595605B2 (ja) | ２−置換オキシイミノ−３−オキソ酪酸の製造法 | |
| JPS6351389A (ja) | セフアロスポリン誘導体、その製造法及び抗菌活性組成物 | |
| FR2475554A1 (fr) | 7-((2-amino-4-thiazolyl)(carboxy(alkylthio)alcoxyimino)-acetamido)cephalospori-nes a action anti-bacterienne | |
| JPH04211088A (ja) | ７−アミノ−３−メトキシメチル−セフ−３−エム−４−カルボン酸の製法 | |
| KR950009828B1 (ko) | 아릴아미노티아졸초산 및 그 제조방법 | |
| HU201034B (en) | Process for production of intermediere compositions of tiasole of cefalosporine | |
| RU2021274C1 (ru) | Способ получения аминотиазолильных производных цефалоспорина | |
| JPS58154588A (ja) | ３−置換チオメチルセフアロスポリン誘導体の製造法 | |
| EP0638574A1 (en) | Oxime derivatives of cephalosporanic structure and compounds for their preparation | |
| JPH10130272A (ja) | ２−カルボキシペナム誘導体またはその塩の製造法 |